198 related articles for article (PubMed ID: 25999742)
1. Positive correlation between expression level of mitochondrial serine hydroxymethyltransferase and breast cancer grade.
Yin K
Onco Targets Ther; 2015; 8():1069-74. PubMed ID: 25999742
[TBL] [Abstract][Full Text] [Related]
2. Roles of Mitochondrial Serine Hydroxymethyltransferase 2 (SHMT2) in Human Carcinogenesis.
Zeng Y; Zhang J; Xu M; Chen F; Zi R; Yue J; Zhang Y; Chen N; Chin YE
J Cancer; 2021; 12(19):5888-5894. PubMed ID: 34476002
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma.
Wang B; Wang W; Zhu Z; Zhang X; Tang F; Wang D; Liu X; Yan X; Zhuang H
Clin Neurol Neurosurg; 2017 Mar; 154():28-33. PubMed ID: 28107674
[TBL] [Abstract][Full Text] [Related]
4. Human Cytosolic and Mitochondrial Serine Hydroxymethyltransferase Isoforms in Comparison: Full Kinetic Characterization and Substrate Inhibition Properties.
Tramonti A; Nardella C; di Salvo ML; Barile A; Cutruzzolà F; Contestabile R
Biochemistry; 2018 Dec; 57(51):6984-6996. PubMed ID: 30500180
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y
Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119
[TBL] [Abstract][Full Text] [Related]
6. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.
Ji L; Tang Y; Pang X; Zhang Y
Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360
[TBL] [Abstract][Full Text] [Related]
7. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients.
Shi H; Fang X; Li Y; Zhang Y
Med Sci Monit; 2019 Oct; 25():7430-7438. PubMed ID: 31581160
[TBL] [Abstract][Full Text] [Related]
8. Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
Bernhardt S; Bayerlová M; Vetter M; Wachter A; Mitra D; Hanf V; Lantzsch T; Uleer C; Peschel S; John J; Buchmann J; Weigert E; Bürrig KF; Thomssen C; Korf U; Beissbarth T; Wiemann S; Kantelhardt EJ
Breast Cancer Res; 2017 Oct; 19(1):112. PubMed ID: 29020998
[TBL] [Abstract][Full Text] [Related]
9. Serine hydroxymethyltransferase 2 knockdown induces apoptosis in ccRCC by causing lysosomal membrane permeabilization via metabolic reprogramming.
Liu Z; Fan M; Hou J; Pan S; Xu Y; Zhang H; Liu C; Hao X; Li X; Wang H
Cell Death Dis; 2023 Feb; 14(2):144. PubMed ID: 36806313
[TBL] [Abstract][Full Text] [Related]
10. SHMT1 knockdown induces apoptosis in lung cancer cells by causing uracil misincorporation.
Paone A; Marani M; Fiascarelli A; Rinaldo S; Giardina G; Contestabile R; Paiardini A; Cutruzzolà F
Cell Death Dis; 2014 Nov; 5(11):e1525. PubMed ID: 25412303
[TBL] [Abstract][Full Text] [Related]
11. High expression of SHMT2 is correlated with tumor progression and predicts poor prognosis in gastrointestinal tumors.
Liu Y; Yin C; Deng MM; Wang Q; He XQ; Li MT; Li CP; Wu H
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9379-9392. PubMed ID: 31773687
[TBL] [Abstract][Full Text] [Related]
12. Cancer proteome and metabolite changes linked to SHMT2.
Tong J; Krieger JR; Taylor P; Bagshaw R; Kang J; Jeedigunta S; Wybenga-Groot LE; Zhang W; Badr H; Mirhadi S; Pham NA; Coyaud É; Yu M; Li M; Cabanero M; Raught B; Maynes JT; Hawkins C; Tsao MS; Moran MF
PLoS One; 2020; 15(9):e0237981. PubMed ID: 32903271
[TBL] [Abstract][Full Text] [Related]
13. Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma.
Woo CC; Chen WC; Teo XQ; Radda GK; Lee PT
Oncotarget; 2016 Aug; 7(33):53005-53017. PubMed ID: 27391339
[TBL] [Abstract][Full Text] [Related]
14. Identification of three new compounds that directly target human serine hydroxymethyltransferase 2.
Han Y; He L; Qi Y; Zhao Y; Pan Y; Fang B; Li S; Zhang JZH; Zhang L
Chem Biol Drug Des; 2021 Feb; 97(2):221-230. PubMed ID: 32779873
[TBL] [Abstract][Full Text] [Related]
15. Differential 3-bromopyruvate inhibition of cytosolic and mitochondrial human serine hydroxymethyltransferase isoforms, key enzymes in cancer metabolic reprogramming.
Paiardini A; Tramonti A; Schirch D; Guiducci G; di Salvo ML; Fiascarelli A; Giorgi A; Maras B; Cutruzzolà F; Contestabile R
Biochim Biophys Acta; 2016 Nov; 1864(11):1506-17. PubMed ID: 27530298
[TBL] [Abstract][Full Text] [Related]
16. Metformin Is a Pyridoxal-5'-phosphate (PLP)-Competitive Inhibitor of SHMT2.
Tramonti A; Cuyàs E; Encinar JA; Pietzke M; Paone A; Verdura S; Arbusà A; Martin-Castillo B; Giardina G; Joven J; Vazquez A; Contestabile R; Cutruzzolà F; Menendez JA
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439169
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT2 by antifolate drugs.
Scaletti E; Jemth AS; Helleday T; Stenmark P
FEBS Lett; 2019 Jul; 593(14):1863-1873. PubMed ID: 31127856
[TBL] [Abstract][Full Text] [Related]
18. SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma.
Ning S; Ma S; Saleh AQ; Guo L; Zhao Z; Chen Y
Gastroenterol Res Pract; 2018; 2018():4369253. PubMed ID: 30228815
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Profiling Reveals a Dependency of Human Metastatic Breast Cancer on Mitochondrial Serine and One-Carbon Unit Metabolism.
Li AM; Ducker GS; Li Y; Seoane JA; Xiao Y; Melemenidis S; Zhou Y; Liu L; Vanharanta S; Graves EE; Rankin EB; Curtis C; Massagué J; Rabinowitz JD; Thompson CB; Ye J
Mol Cancer Res; 2020 Apr; 18(4):599-611. PubMed ID: 31941752
[TBL] [Abstract][Full Text] [Related]
20. SHMT2 promotes tumor growth through VEGF and MAPK signaling pathway in breast cancer.
Xie SY; Shi DB; Ouyang Y; Lin F; Chen XY; Jiang TC; Xia W; Guo L; Lin HX
Am J Cancer Res; 2022; 12(7):3405-3421. PubMed ID: 35968337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
